Technical Resources
Data Download
Maintaining the balance between immunity and tolerance of immune cells is strongly controlled by several sophisticated regulatory mechanisms of the immune system, among which the E3 ligase ubiquitin Casitas B cell lymphoma-b (Cbl-b) appears to be a central player.Cbl-b is newly identified component in the ubiquitin-dependent protein degradation system, which is thought to be an important negative regulator of immune cells. Ubiquitin ligase targeting could be a novel approach to human disease therapy, such as in autoimmunity and cancer.
